title: Exacerbation of cerebral radiation necrosis by bevacizumab.
authors.affiliation: Massachusetts General Hospital, Boston, MA, USA.
authors.forename: Deva Sanjeeva
authors.initials: DS
authors.lastname: Jeyaretna
authors.forename: William T
authors.initials: WT
authors.lastname: Curry
authors.forename: Tracy T
authors.initials: TT
authors.lastname: Batchelor
authors.forename: Anat
authors.initials: A
authors.lastname: Stemmer-Rachamimov
authors.forename: Scott R
authors.initials: SR
authors.lastname: Plotkin
mesh_terms: D000328:Adult; D020533:Angiogenesis Inhibitors / Q000009:adverse effects; D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D001254:Astrocytoma / Q000175:diagnosis / Q000532:radiotherapy* / Q000601:surgery; D000068258:Bevacizumab; D001932:Brain Neoplasms / Q000175:diagnosis / Q000532:radiotherapy* / Q000601:surgery; D018450:Disease Progression; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D009336:Necrosis / Q000188:drug therapy / Q000473:pathology; D011832:Radiation Injuries / Q000188:drug therapy* / Q000473:pathology*; D018570:Risk Assessment; D012720:Severity of Illness Index; D016896:Treatment Outcome
chemical_list: D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab